Pre-Treatment Status and Changes in Autoantibodies, Lymphocytic Populations, Cytokines and VEGF during Sunitinib Treatment of Metastatic Renal Cell Carcinoma (mRCC)

Alexandra Karadimou^1*, Nikos Gavalas¹, Marinos Tsiatas¹, Eleni Sereti², Paraskevi-Sofia Trachana¹, Maria Spyropoulou-Vlachou², Eleni Karga³, Evangelos Terpos¹, Ourania Tsitsilonis⁴, Meletios A. Dimopoulos¹ and Aristotelis Bamias¹

¹Department of Clinical Therapeutics, University of Athens, Medical School, Athens, Greece

²Immunology Department, Alexandra Hospital, Athens, Greece

³Endocrinology Department, Alexandra Hospital, Athens, Greece

⁴School of Biology, University of Athens, Athens, Greece

^*Corresponding Author: Alexandra Karadimou, 1 Nikou Rizou Str, 18547, Neo Faliro, Piraeus, Greece Email: